Moderna, Inc. balance sheet
At the end of its fiscal year on Dec 31, 2025, Moderna, Inc. reported total assets of $12.34B and shareholders' equity of $8.65B. That works out to liabilities equal to 30% of assets, a current ratio of 3.29 (current assets ÷ current liabilities), long-term debt of 0.07× shareholders' equity.
Balance sheet at each fiscal year end
| Fiscal year ended | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | $1.08B | $1.96B | $1.59B | $7.34B | $24.67B | $25.86B | $18.43B | $14.14B | $12.34B |
| Current assets | — | $783.22M | $1.56B | $1.13B | $6.30B | $16.07B | $13.43B | $10.32B | $8.10B | $6.54B |
| Cash & equivalents | $50.08M | $134.86M | $658.36M | $236.00M | $2.62B | $6.85B | $3.21B | $2.91B | $1.93B | $2.60B |
| Total liabilities | — | $459.19M | $431.91M | $414.61M | $4.78B | $10.52B | $6.74B | $4.57B | $3.24B | $3.69B |
| Current liabilities | — | $191.46M | $222.80M | $143.12M | $4.39B | $9.13B | $4.92B | $3.02B | $2.21B | $1.99B |
| Long-term debt | — | — | — | — | — | — | — | — | $0 | $590.00M |
| Shareholders' equity | −$334.81M | −$551.37M | $1.53B | $1.18B | $2.56B | $14.14B | $19.12B | $13.85B | $10.90B | $8.65B |
| Reported in | 10-K 2019 | 10-K 2019 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 |
Balance-sheet figures are point-in-time values on the last day of each fiscal year. Some companies (for example banks and insurers) do not present current assets and liabilities; those cells show —.
Source: SEC EDGAR XBRL company facts for CIK 1682852 (raw data). Most recent filing in this dataset: 10-Q filed Jul 31, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.